Examining HRSA's Oversight of the 340B Drug Pricing Program
House Committee on Energy and Commerce: Subcommittee on Oversight and Investigations Testimony on Examining HRSA's Oversight of the 340B Drug Pricing Program
July 18, 2017, 1:15 p.m.
Erin Bliss, Assistant Inspector General for Evaluation and Inspections, Office of Inspector General, U.S. Department of Health and Human Services